Insulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal women

Korean Journal of Internal Medicine

Volumn 26, Issue 3, 2011, Pages 285-293

  Kim, Sang Soo ^a   Lee, Jeong Gyu ^a   Kim, Dong Wok ^a   Kim, Bo Hyun ^a   Jeon, Yun Kyung ^a   Kim, Mi Ra ^a   Huh, Jeong Eun ^a   Mok, Ji Young ^a   Kim, Seong Jang ^a   Kim, Yong Ki ^a   Kim, In Joo ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Gallstones; Insulin resistance; Metabolic syndrome; Postmenopause

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; AGE; AGED; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GALLSTONE FORMATION; HOMEOSTASIS MODEL OF ASSESSMENT INSULIN RESISTANCE INDEX; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; KOREAN; MAJOR CLINICAL STUDY; OBESITY; POPULATION RESEARCH; POSTMENOPAUSE; PREMENOPAUSE; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; FEMALE; GALLSTONES; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MIDDLE AGED; OBESITY, ABDOMINAL; ODDS RATIO; POSTMENOPAUSE; QUESTIONNAIRES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS;

EID: 80054848241     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2011.26.3.285     Document Type: Article

References (31)

1. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999;117:632-639.
2. Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006;20:981-996.
3. Nervi F, Miquel JF, Alvarez M, et al. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J Hepatol 2006;45:299-305.
4. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005;11:1653-1657.
5. George ED, Schluger LK. Special women's health issues in hepatobiliary diseases. Clin Fam Pract 2000;2:155-169.
6. Kim Sw, Park YH, Choi JW. Clinical and epidemiological analysis of 10-year experienced 1,719 gallstone patients. Korean J Gastroenterol 1993;25:159-167.
7. Kim MH, Lim BC, Myung SJ, et al. Epidemiological study on Korean gallstone disease: a nationwide cooperative study. Dig Dis Sci 1999;44:1674-1683.
8. Park YH, Park SJ, Jang JY, et al. Changing patterns of gallstone disease in Korea. World J Surg 2004;28:206-210.
9. Yang SH, Lee SE, Jang JY, et al. Clinical and epidemiological analysis of gallstone patients focused on 25-year experience of surgically treated patients. Korean J Gastroenterol 2007;50:42-50.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
11. Filly RA, Allen B, Minton MJ, Bernhoft R, Way LW. In vitro investigation of the origin of echoes with biliary sludge. J Clin Ultrasound 1980;8:193-200.
12. Carol AM. General ultrasound. Edinburgh: Churchill Livingstone, 1992.
13. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition: A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
14. Lee SY, Park HS, Kim DJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72-80.
15. Diehl AK. Cholelithiasis and the insulin resistance syndrome. Hepatology 2000;31:528-530.
16. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000;31:299-303.
17. Nepokroeff CM, Lakshmanan MR, Ness GC, Dugan RE, Porter JW. Regulation of the diurnal rhythm of rat liver beta-hydroxybeta- methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone. Arch Biochem Biophys 1974;160:387-396.
18. Storer GB, Topping DL, Trimble RP. Direct stimulation by glucose and insulin of glycogen synthesis in perfused rat liver. FEBS Lett 1981;136:135-137.
19. Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J (Clin Res Ed) 1984;289:521-525.
20. Haffner SM, Diehl AK, Mitchell BD, Stern MP, Hazuda HP. Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990;132:327-335.
21. Chang Y, Sung E, Ryu S, Park YW, Jang YM, Park M. Insulin resistance is associated with gallstones even in non-obese, nondiabetic Korean men. J Korean Med Sci 2008;23:644-650.
22. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989;321:563-569.
23. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut 2006;55:708-714.
24. Uhler ML, Marks JW, Voigt BJ, Judd HL. Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women. J Clin Endocrinol Metab 1998;83:410-414.
25. Thijs C, Knipschild P. Oral contraceptives and the risk of gallbladder disease: a meta-analysis. Am J Public Health 1993;83:1113-1120.
26. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/ progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
27. Cirillo DJ, Wallace RB, Rodabough RJ, et al. Effect of estrogen therapy on gallbladder disease. JAMA 2005;293:330-339.
28. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990;99:843-849.
29. Petitti DB, Friedman GD, Klatsky AL. Association of a history of gallbladder disease with a reduced concentration of highdensity-lipoprotein cholesterol. N Engl J Med 1981;304:1396-1398.
30. Valdivieso V, Covarrubias C, Siegel F, Cruz F. Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium. Hepatology 1993;17:1-4.
31. Maringhini A, Ciambra M, Baccelliere P, et al. Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history. Ann Intern Med 1993;119:116-120.